Literature DB >> 10394937

Association between coding variability in the LRP gene and the risk of late-onset Alzheimer's disease.

F Wavrant-DeVrièze1, J C Lambert, L Stas, R Crook, D Cottel, F Pasquier, B Frigard, M Lambrechts, E Thiry, P Amouyel, J Pérez-Tur, M C Chartier-Harlin, J Hardy, F Van Leuven.   

Abstract

We have sequenced the entire (89 exons) open reading frame of the LRP gene in 12 cases of Alzheimer's disease (AD) from Northern France. We have found no novel changes but confirm the occurrence of a polymorphism in exon 6 of the gene (A216V). This polymorphism is rare (2.8% of controls) and is in linkage equilibrium with previously reported polymorphisms. The V216 allele is negatively associated with the disease in a large case-controlled series. These data suggest that the LRP receptor may be involved in the pathobiology of AD, but the association that we report here cannot explain the previously reported genetic data implicating the LRP gene in AD. If the LRP gene is a major site of genetic variability leading to AD, there must be other biologically relevant variability in promoter or other regulatory elements of this large gene.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10394937     DOI: 10.1007/s004390050980

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  15 in total

Review 1.  Low-density lipoprotein receptor family: endocytosis and signal transduction.

Authors:  Y Li; J Cam; G Bu
Journal:  Mol Neurobiol       Date:  2001-02       Impact factor: 5.590

Review 2.  The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease.

Authors:  R Deane; A Sagare; B V Zlokovic
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 3.  [Current immune therapy for Alzheimer's disease].

Authors:  T Grimmer; R Perneczky; A Kurz
Journal:  Nervenarzt       Date:  2008-07       Impact factor: 1.214

Review 4.  Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities.

Authors:  Abhay P Sagare; Rashid Deane; Berislav V Zlokovic
Journal:  Pharmacol Ther       Date:  2012-07-20       Impact factor: 12.310

Review 5.  Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.

Authors:  Abhay P Sagare; Robert D Bell; Berislav V Zlokovic
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

6.  Overexpression of amyloid precursor protein induces susceptibility to oxidative stress in human neuroblastoma SH-SY5Y cells.

Authors:  K Matsumoto; Y Akao; H Yi; M Shamoto-Nagai; W Maruyama; M Naoi
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

Review 7.  Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain.

Authors:  Berislav V Zlokovic; Rashid Deane; Abhay P Sagare; Robert D Bell; Ethan A Winkler
Journal:  J Neurochem       Date:  2010-10-05       Impact factor: 5.372

Review 8.  Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.

Authors:  R Deane; R D Bell; A Sagare; B V Zlokovic
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-03       Impact factor: 4.388

9.  Increased soluble amyloid-beta peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein.

Authors:  Celina V Zerbinatti; David F Wozniak; John Cirrito; Judy A Cam; Hiroshi Osaka; Kelly R Bales; Min Zhuo; Steven M Paul; David M Holtzman; Guojun Bu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-19       Impact factor: 11.205

10.  C-terminal 37 residues of LRP promote the amyloidogenic processing of APP independent of FE65.

Authors:  Madepalli K Lakshmana; Eunice Chen; Il-Sang Yoon; David E Kang
Journal:  J Cell Mol Med       Date:  2008-03-28       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.